Zantac / Ranitidine (NDMA Cancer) Attorney in San Antonio, Texas

Zantac Litigation in San Antonio

San Antonio's large military and retired military population and significant Hispanic community represent demographics with documented long-term OTC ranitidine use. Military personnel and veterans who used ranitidine through military pharmacies (TriCare formulary) prior to the 2020 FDA withdrawal may have particularly strong Zantac exposure documentation through military medical records. Texas applies Daubert under Tex. R. Evid. 702. The federal Zantac MDL (No. 2924, S.D. Florida) was largely dismissed in 2022 after Judge Robin Rosenberg excluded plaintiffs' causation experts under Daubert. However, the Delaware Superior Court under Judge Vivian Medinilla continues to actively hear Zantac cases and has allowed causation experts to proceed. Defendants Sanofi, Boehringer Ingelheim, GSK, and Pfizer are all actively litigating in Delaware. For most claimants, filing in Delaware Superior Court through national plaintiffs' counsel is now the primary path forward.

Documentation for San Antonio Zantac Claimants

San Antonio-area Zantac claimants should request military pharmacy records through the Military Health System (MHS) if applicable, as well as records from HEB Pharmacy, Walgreens, and CVS. Medical records from the UT Health San Antonio Mays Cancer Center or Methodist Cancer Center documenting cancer diagnosis and treatment are critical. Texas's 2-year SOL requires immediate consultation with qualified Zantac plaintiffs' counsel.